Evans Jonathan P, Sutton Paul A, Winiarski Boleslaw K, Fenwick Stephen W, Malik Hassan Z, Vimalachandran Dale, Tweedle Elizabeth M, Costello Eithne, Palmer Daniel H, Park B Kevin, Kitteringham Neil R
Institute of Translational Medicine, University of Liverpool, United Kingdom.
Institute of Translational Medicine, University of Liverpool, United Kingdom; Department of Colorectal Surgery, Countess of Chester Hospital NHS Foundation Trust, United Kingdom.
Crit Rev Oncol Hematol. 2016 Feb;98:94-105. doi: 10.1016/j.critrevonc.2015.10.009. Epub 2015 Nov 1.
Colorectal cancer (CRC) is the third most common carcinoma worldwide and despite advances in treatment, survival for patients with metastatic disease remains poor. With nearly 50% of patients developing metastases, in vivo investigation is essential to improve outcomes for these patients and numerous murine models of CRC have been developed to allow the study of chemoprevention and chemotherapy, in addition to improving our understanding of the pathogenesis of CRC. Selecting the most appropriate murine model for a specific application will maximize the conversion of potential therapies from the laboratory to clinical practice and requires an understanding of the various models available. This review will provide an overview of the murine models currently used in CRC research, discussing the limitations and merits of each and their most relevant application. It is aimed at the developing researcher, acting as a guide to prompt further reading in planning a specific study.
结直肠癌(CRC)是全球第三大常见癌症,尽管治疗方法有所进步,但转移性疾病患者的生存率仍然很低。近50%的患者会发生转移,因此体内研究对于改善这些患者的治疗效果至关重要,并且已经开发了许多CRC小鼠模型,以研究化学预防和化疗,同时增进我们对CRC发病机制的理解。为特定应用选择最合适的小鼠模型将最大限度地提高潜在疗法从实验室到临床实践的转化率,这需要了解现有的各种模型。本综述将概述目前用于CRC研究的小鼠模型,讨论每种模型的局限性和优点及其最相关的应用。它针对的是初出茅庐的研究人员,作为在规划特定研究时促使进一步阅读的指南。